The European Commission said Wednesday it had forced South African drugs giant Aspen to slash prices on six cancer drugs after finding it abused its market dominance to hike charges.
Feb 10, 2021
0
0
Prescription drug prices in the United States are significantly higher than in other nations, with prices in the U.S. averaging 2.56 times those seen in 32 other nations, according to a new RAND Corporation report.
Jan 28, 2021
0
6
With the new year comes another round of prescription drug price hikes, CBS News reported Tuesday.
Jan 7, 2021
0
2
More than 1.1 million Medicare patients could die over the next decade because they cannot afford to pay for their prescription medications, according to a new study released today by the West Health Policy Center, a nonprofit ...
Nov 19, 2020
0
3
The NHS would spend billions of pounds more on drugs if it had to pay US prices following a US/UK trade deal. According to a new study by researchers at Brigham and Women's Hospital in Boston, Harvard Medical School, and ...
Sep 11, 2020
0
3
Conventional drug costing models are unlikely to apply when it comes to putting a price tag on a vaccine against COVID-19 for Canadians, according to health economist Christopher McCabe of the University of Alberta's Faculty ...
Sep 3, 2020
0
2
Is the basic research that goes into the development of new drugs more efficiently conducted by public-sector scientists, pharmaceutical firms, or independent private laboratories? What role do each of these groups play in ...
Jun 29, 2020
0
2
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other ...
Jun 29, 2020
0
7
Nearly 9 in 10 U.S. adults are "very" (55%) or "somewhat" (33%) concerned that the pharmaceutical industry will leverage the COVID-19 pandemic to raise drug prices. Similarly, 84% are very or somewhat concerned that the general ...
Jun 18, 2020
0
1
After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual ...
May 1, 2020
0
4
